Back to Search
Start Over
Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder : A Promising Case of Preclinical-Clinical Translation?
- Publication Year :
- 2022
- Publisher :
- Linköpings universitet, Centrum för social och affektiv neurovetenskap, 2022.
-
Abstract
- The endocannabinoid (eCB) system is one the most ubiquitous signaling systems of the brain and offers a rich pharmacology including multiple druggable targets. Preclinical research shows that eCB activity influences functional connectivity between the prefrontal cortex and amygdala and thereby influences an organisms ability to cope with threats and stressful experiences. Animal studies show that CB1 receptor activation within the amygdala is essential for extinction of fear memories. Failure to extinguish traumatic memories is a core symptom of posttraumatic stress disorder, suggesting that potentiating eCB signaling may have a therapeutic potential in this condition. However, it has been unknown whether animal findings in this domain translate to humans. Data to inform this critical question are now emerging and are the focus of this review. We first briefly summarize the biology of the eCB system and the animal studies that support its role in fear extinction and stress responding. We then discuss the pharmacological eCB-targeting strategies that may be exploited for therapeutic purposes: direct CB1 receptor activation, using Delta(9)-tetrahydrocannabinol or its synthetic analogs; or indirect potentiation, through inhibition of eCB-degrading enzymes, the anandamide-degrading enzyme fatty acid amide hydrolase; or the 2-AG (2-arachidonoyl glycerol)-degrading enzyme monoacylglycerol lipase. We then review recent human data on direct CB1 receptor activation via Delta(9)-tetrahydrocannabinol and anandamide potentiation through fatty acid amide hydrolase blockade. The available human data consistently support a translation of animal findings on fear memories and stress reactivity and suggest a potential therapeutic utility in humans. Funding Agencies|Swedish Research CouncilSwedish Research CouncilEuropean Commission [2013-07434, 2019-01138]; Brain & Behavior Research FoundationNARSAD [27094]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R33MH111935, R01MH122867]
- Subjects :
- Cannabinoid receptor
Traumatic memories
Amygdala
Amidohydrolases
Extinction, Psychological
Stress Disorders, Post-Traumatic
chemistry.chemical_compound
Receptor, Cannabinoid, CB1
Fatty acid amide hydrolase
Animals
Humans
Medicine
Biological Psychiatry
business.industry
Neurosciences
Fear
Anandamide
Extinction (psychology)
Endocannabinoid system
Monoacylglycerol lipase
medicine.anatomical_structure
chemistry
business
Neuroscience
Neurovetenskaper
Endocannabinoids
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....0c3a7120445c983a05f76a738cbd2f1d